Context: Opioid use disorder (OUD) has a considerable morbidity and mortality in the United States. Healthcare providers are key points of contact for those with OUD; however, some providers may hold stigma toward OUD. Stigma toward OUD can lead to lower quality of care and more negative health outcomes. Thus, new trainings designed to reduce stigma toward OUD while increasing empathy are critical. We created a web-based cinematic virtual reality (cine-VR) training program on OUD for osteopathic medical students.
Objectives: The aim of this pilot study was to assess changes in stigma toward OUD and empathy before and after the online cine-VR training program on OUD.
Methods: We employed a single-arm, pre- and posttest pilot study to assess changes in stigma toward OUD and empathy. Osteopathic medical students from one large medical school in the Midwest with three campuses were invited to participate in the online cine-VR training. Participants completed two surveys before and after the cine-VR training. We performed paired t tests to examine changes in stigma toward OUD and empathy scores before and after the cine-VR OUD training program.
Results: A total of 48 participants completed the training. We observed a decrease in stigma toward OUD posttraining (=4.402, p<0.001); this change had a Cohen's of 0.64, indicating a medium effect. We also observed an increase in participants' empathy scores posttraining (=-2.376, p=0.023), with a Cohen's of 0.40 signifying a small effect.
Conclusions: Findings from this pilot study suggest that the online cine-VR training may reduce stigma toward OUD while increasing empathy. Future research employing a randomized controlled trial design with a larger, more diverse sample and a proper attention control condition is needed to confirm the effectiveness of the online cine-VR training. If confirmed, this cine-VR training may be an accessible approach to educating osteopathic medical students about OUD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1515/jom-2023-0188 | DOI Listing |
Harm Reduct J
December 2024
Sexual and Reproductive Health Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Subst Abuse Treat Prev Policy
December 2024
JBS International, 11200 Rockville Pike, Suite 320, North Bethesda, MD, 20852, USA.
Background: Section 1262 Consolidated Appropriations Act of 2023 eliminates the federal DATA waiver registration requirement to prescribe buprenorphine for opioid use disorder (OUD), along with patient limits, perhaps as a way to increase provider capacity to prescribe buprenorphine. Understanding the factors that influence provider capacity, patient access, and whether community need for MAT is met could inform how to capitalize on DATA waiver eliminations in the United States.
Methods: This observational study utilized required reporting from two cohorts of the Rural Communities Opioid Response Program (RCORP).
Prev Med
December 2024
Crown Family School of Social Work, Policy, and Practice, University of Chicago, Chicago, IL, United States; Department of Public Health Sciences, University of Chicago, Chicago, IL, United States; Urban Health Lab, University of Chicago, Chicago, IL, United States.
Objective: To examine associations between passive exposure to opioid crisis information and public attitudes toward opioid use disorder (OUD) policies and stigma among United States (US) adults.
Methods: A nationally representative survey of 6543 US adults was conducted from December 2023 to January 2024. Participants reported passive exposure to opioid crisis information from various sources.
Addict Sci Clin Pract
December 2024
Department of Population and Quantitative Health Sciences, UMass Chan School of Medicine, Worcester, MA, USA.
Introduction: Receipt of medications for opioid use disorder (MOUD) critically reduces opioid-related mortality during the post-incarceration period. Optimal provision of this care to individuals on community supervision (i.e.
View Article and Find Full Text PDFBMC Glob Public Health
May 2024
Department of Human Development and Family Studies, Pennsylvania State University, State College, PA, 16801, USA.
Background: Women with substance use disorders (SUDs) often experience adversity related to incarceration and reentry that can impact their substance use outcomes. This study aims to examine the adverse effects of incarceration and reentry on substance use outcomes among women with a history of opioid use disorder (OUD).
Methods: We carried out 42 semi-structured interviews (May-July 2022) with women with a history of criminal legal involvement and OUD (n = 20), criminal legal professionals (n = 10), and SUD treatment professionals (n = 12).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!